DEF 14AThe Ballot
Spyre Therapeutics, Inc. files DEF 14A
Filed Sep 6, 2018 · 7y ago · Accession 0001564590-18-022770
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- DEF 14A
- Filing date
- Sep 6, 2018
- Report date
- Oct 8, 2018
- Document
- agle-def14a_20181008.htm
- Size
- 1.1 MB